|
Seoyoung C. Kim, MD, ScD, MSCESeoyoung C. Kim, M.D, Sc.D., M.S.C.E, is Associate Professor of Medicine at Harvard Medical School and the Director of the Program in Rheumatologic, Immunologic, and Musculoskeletal Pharmacoepidemiology in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She is board-certified in Rheumatology, and co-appointed in the Division of Rheumatology, Inflammation, and Immunity at Brigham and Women’s Hospital. In addition, she is Instructor in Epidemiology and co-directs EPI 253: Effectiveness Research with Longitudinal Healthcare Databases at Harvard T.H. Chan School of Public Health. Her research focuses on comparative safety and effectiveness of medications for the rheumatic diseases as well as health services/outcome research in Rheumatology. She is an Associate Editor for Arthritis Care and Research and ACR Open Rheumatology. Dr. Kim graduated from the College of Medicine at Hanyang University in Seoul, Korea and completed residency training in Internal Medicine at State University of New York at Buffalo. She finished her fellowship training in rheumatology at the University of Pennsylvania and Brigham and Women’s Hospital. She received a master’s degree in Clinical Epidemiology at the University of Pennsylvania and a doctoral degree in Epidemiology at Harvard T.H. Chan School of Public Health.
|
|
PRIME is a program of Division of Phamacoepidemiology & Pharmacoeconomics
|
|